Tarini Lifesciences Limited.(TLL)

TLSL aims to manufacturer high value formulations in the Beta lactam formulations in various dosage forms, in the Anti-Infective segment, in the semi regulated markets, by creating a high class manufacturing facility, meeting WHO- GMP standards.

Initially TLSL will target the domestic and semi-regulated export markets. In phase II, after about three years, it would seek to graduate to USFDA and EU GMP standards, by upgrading the facilities for manufacturing similar high value formulations for established pharmaceutical companies using exclusive patented technologies. TLSL is further keen on leveraging the fast growing healthcare market in the African Continent by way of exporting its produce.